Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Board/Management Information 2010

Apr 22, 2010

34807_rns_2010-04-22_76c7646c-74bd-495b-a197-6b05d347b8d1.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 v181930_8k.htm Unassociated Document Licensed to: Vintage Filings Document Created using EDGARizer 4.0.6.1 Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

April 19, 2010

(Exact
name of registrant as specified in its charter)
Delaware 000-30975 911789357
(State
of Incorporation) (Commission
File Number) (IRS
Employer Identification Number)
12325
Emmet Street, Omaha, Nebraska 68164
(Address
of principal executive offices) (Zip
Code)
(402)
452-5400
(Registrant’s
telephone number, including area code)
Not
applicable
(Former
name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02(e) Compensatory Arrangement of Certain Officer.

On April 19, 2010, the registrant entered into a Separation Agreement with Dr. Eric Kaldjian, former Chief Scientific Officer of the registrant. Pursuant to the Separation Agreement, Dr. Kaldjian’s employment with the registrant ended as of April 9, 2010, however the registrant shall continue to pay Dr. Kaldjian’s base salary through December 31, 2010. The Separation Agreement also contains customary confidentiality, non-competition, non-solicitation and release of claims provisions.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Dated: April

22, 2010
By: /s/ Debra
A. Schneider
Debra
A. Schneider
Chief
Financial Officer